EXV-801

· Exciva GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EXV-801, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia [Phase 2, Phase 3]

See pricing